Bruce N. Jacobs, CFO: Kymera Therapeutics KYMR Sell · Filed 25/09/17

Trade details

Type: Insider sale
Amount: $3,961,000
Shares · price: 79,220 sh · $50.00 a share
Held after: 227,409 sh
Stock: Kymera Therapeutics KYMR
Person: Bruce N. JacobsCFO
Trade date: 25/09/17
Filed: 25/09/17
Days to filing: 0 days

Sold 25.8% of holdings

Share of holding sold: 25.8%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/18~25/10/17

Bruce N. Jacobs's recent trades

Bruce N. JacobsCFO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$8.4M
77,109 sh
$8.4M
Filed 06/30
Traded 06/30
Bruce N. JacobsCFO
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$368.8K
4,113 sh
$368.8K
Filed 03/04
Traded 03/02
Bruce N. JacobsCFO
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$214.2K
2,519 sh
$214.2K
Filed 03/04
Traded 03/04
Bruce N. JacobsCFO
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$178.9K
2,039 sh
$178.9K
Filed 03/04
Traded 03/02
Bruce N. JacobsCFO
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$126K
1,424 sh
$126K
Filed 03/04
Traded 03/02